FASLG and neoplasm: Various data from in-vitro and in-vivo studies suggest an association between the expression of FasL, which is present in numerous tumours [20-23], and a significant localized reduction of tumor-infiltrating lymphocytes (TILs)[24] secondary to apoptosis of sensitive T-cells [23,25].